source
- STAT+: Top lawmaker takes aim at doctor lobby, linking AMA’s billing codes to fraud fightA top Republican is asking if the AMA's codes are helping to fuel health care fraud.STAT · 2mo ago↗ source
- STAT+: Johnson & Johnson advances IBD therapy, despite trial missA closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD patients.STAT · 2mo ago↗ source
- Vertex drops mRNA cystic fibrosis program over 'tolerability' issuesVertex Pharmaceuticals said it has dropped development of an mRNA-based cystic fibrosis therapy after facing challenges similar to those that have troubled other parts of the field in delivering th…Endpoints · 2mo ago↗ source